SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-192990
Filing Date
2018-06-14
Accepted
2018-06-14 16:37:35
Documents
3
Period of Report
2018-06-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d585389d8k.htm 8-K 21753
2 EX-10.1 d585389dex101.htm EX-10.1 43195
3 EX-10.2 d585389dex102.htm EX-10.2 42611
  Complete submission text file 0001193125-18-192990.txt   109057
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35405 | Film No.: 18899607
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences